Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Oct 31:4:468.
doi: 10.1186/1756-0500-4-468.

Molecular epidemiology of hepatitis C infection in Cyprus within the general population and high-risk cohorts

Affiliations

Molecular epidemiology of hepatitis C infection in Cyprus within the general population and high-risk cohorts

Victoria L Demetriou et al. BMC Res Notes. .

Abstract

Background: Initial data on the molecular epidemiology of HCV infection in Cyprus showed a highly polyphyletic infection and multiple points of introduction into the general population. The continuation and expansion of this investigation is presented here including high risk groups.

Findings: The samples include additional subjects from the general population, a group of inmates and HIV/HCV coinfected individuals, whose strains were amplified by RT-PCR and sequenced in partial Core-E1 and NS5B regions. The results confirm the broad genotype distribution and polyphyletic infection on the island, and no new subtypes were found. Monophyletic clusters between strains of the prisoners and the injecting drug users imply sharing of infected equipment, and highlight the risk of widespread transmission in these cohorts, although no spill-over to the general population was observed.

Conclusions: The results of this study underline the impact of population movements and high-risk population groups on the changing molecular epidemiology of HCV, with strains moving to Europe from Asia, Africa and Eastern Europe by means of immigration and modern transmission routes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Maximum likelihood tree of partial Core-E1 sequences. Phylogenetic ML tree showing the genotype distribution of the HCV samples discovered in Cyprus sequenced in the Core-E1 genomic regions. HCV subtypes are designated with brackets on the right of each tree. U denotes unclassified strains. The samples are represented with different symbols for each cohort: grey circles denote samples from the general population from 2005-2008, yellow circles the general population from 2008-2010, red squares the incarcerated population, blue triangles the intravenous drug users, and green rhombus the HIV/HCV coinfected individuals. The general population 2005-2008 and the intravenous drug users have been previously described [14,15], and the rest are described in this study. Asterisks at branch nodes indicate bootstrap values of 70 and above. The genetic distance between any two sequences is denoted by the scale at the lower left side of each tree.
Figure 2
Figure 2
Maximum likelihood tree of partial NS5B sequences. Phylogenetic ML tree showing the genotype distribution of the HCV samples discovered in Cyprus sequenced in the NS5B genomic regions. HCV subtypes are designated with brackets on the right of each tree. U denotes unclassified strains. The samples are represented with different symbols for each cohort: grey circles denote samples from the general population from 2005-2008, yellow circles the general population from 2008-2010, red squares the incarcerated population, blue triangles the intravenous drug users, and green rhombus the HIV/HCV coinfected individuals. The general population 2005-2008 and the intravenous drug users have been previously described [14,15], and the rest are described in this study. Asterisks at branch nodes indicate bootstrap values of 70 and above. The genetic distance between any two sequences is denoted by the scale at the lower left side of each tree.

References

    1. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol. 2007;13(17):2436–2441. - PMC - PubMed
    1. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, Halfon P, Inchauspe G, Kuiken C, Maertens G. et al.Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology. 2005;42(4):962–973. doi: 10.1002/hep.20819. - DOI - PubMed
    1. Zeuzem S. Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well? Ann Intern Med. 2004;140(5):370–381. - PubMed
    1. Pybus OG, Charleston MA, Gupta S, Rambaut A, Holmes EC, Harvey PH. The epidemic behavior of the hepatitis C virus. Science. 2001;292(5525):2323–2325. doi: 10.1126/science.1058321. - DOI - PubMed
    1. Morice Y, Cantaloube JF, Beaucourt S, Barbotte L, De Gendt S, Goncales FL, Butterworth L, Cooksley G, Gish RG, Beaugrand M. et al.Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users. J Med Virol. 2006;78(10):1296–1303. doi: 10.1002/jmv.20692. - DOI - PubMed

LinkOut - more resources